Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
RSC Medicinal Chemistry|April 26, 2024
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activityLetizia Crocetti, Francesca Catarzi, Maria Paola Giovannoni, et al.Drug Development Research|December 5, 2019
New 3-unsubstituted isoxazolones as potent human neutrophil elastase inhibitors: Synthesis and molecular dynamic simulationMaria Paola Giovannoni, Letizia Crocetti, Niccolò Cantini, et al.Drug Development Research|November 19, 2016
Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor AgonistsClaudia Vergelli, Igor A Schepetkin, Giovanna Ciciani, et al.Antioxidants (Basel, Switzerland)|June 28, 2023
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid ArthritisValentina Ferrara, Alessandra Toti, Elena Lucarini, et al.European Journal of Medicinal Chemistry|December 3, 2014
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonistsMaria Paola Giovannoni, Giovanna Ciciani, Agostino Cilibrizzi, et al.Bioorganic Chemistry|May 11, 2020
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritisLetizia Crocetti, Claudia Vergelli, Gabriella Guerrini, et al.Molecules (Basel, Switzerland)|November 13, 2021
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid ArthritisLetizia Crocetti, Claudia Vergelli, Gabriella Guerrini, et al.Chemical Biology & Drug Design|June 20, 2021
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonistsClaudia Vergelli, Andrei I Khlebnikov, Letizia Crocetti, et al.Journal of Medicinal Chemistry|October 1, 2009
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced painClaudio Biancalani, Maria Paola Giovannoni, Stefano Pieretti, et al.Bioorganic & Medicinal Chemistry|May 3, 2016
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonistsClaudia Vergelli, Igor A Schepetkin, Giovanna Ciciani, et al.Pageof 6